Ulrike Wehkamp

13PUBLICATIONS
55CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Microbial geneticsHaematological tumoursAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 15, 2025
A new prognostic index (CLIPI) for advanced cutaneous lymphoma enables precise patient risk stratification.

Julia J Scarisbrick, Pietro Quaglino, Sean Whittaker

|Sep 02, 2024
Evaluation of Sézary cell marker expression and cell death behaviour upon in vitro treatment by flow cytometry in Sézary syndrome patients.

S Melchers, M Roemer, J D Albrecht

|May 22, 2023
Dimethyl fumarate treatment in relapsed and refractory cutaneous T-cell lymphoma: a multicenter phase 2 study.

Jan P Nicolay, Susanne Melchers, Jana D Albrecht

|Mar 10, 2022
The Skin Microbiome and Influencing Elements in Cutaneous T-Cell Lymphomas.

Marion Jost, Ulrike Wehkamp

|Jan 06, 2022
Clinical, histopathological and prognostic features of primary cutaneous acral CD8+ T-cell lymphoma and other dermal CD8+ cutaneous lymphoproliferations: results of an EORTC Cutaneous Lymphoma Group workshop.

Werner Kempf, Tony Petrella, Rein Willemze

|Jun 24, 2020
Should we be imaging lymph nodes at initial diagnosis of early-stage mycosis fungoides? Results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) international study.

E Hodak, S Sherman, E Papadavid

Pageof 3

Frequent Collaborators

5 joint publications

Marion Wobser

5 joint publications

Rudolf Stadler

5 joint publications

Emmanuella Guenova

3 joint publications

Julia Scarisbruck